Oncology Institute Inc (The) - Warrants (15/11/2026)
TOIIW
Get informed when a big investor buys or sells
+ FollowMarket Cap$633.47M
Close$
$-5.02
7298.1% downside
Current Fair Value
7298.1% downsideOvervalued by 7298.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $633.47 Million |
|---|---|
| Enterprise Value | $629.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.39 |
| Outstanding Shares | 1,018,016,090 |
Return
| Return on Equity | 267.20% |
|---|---|
| Return on Assets | -25.87% |
| Return on Invested Capital | -41.34% |
Valuation & Multiples
| P/E Ratio | -16.83 |
|---|---|
| PEG | 19.28 |
| Price to Sales | - |
| Price to Book Ratio | -0.07 |
| Enterprise Value to Revenue | 1.15 |
| Enterprise Value to EBIT | -17.13 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | -1.61 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$143.35 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.06
Average shareholder expectationRevenue Estimate
$155.21 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 109,1000% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.38%▼ 0.02% |
|---|---|
| Total Invested | $170,592▼ 79.22% |
| Investors Holding | 130% |
ESG Score
No data